Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT

Nagaya, T; Nakamura, Y; Okuyama, S; Ogata, F; Maruoka, Y; Choyke, PL; Allen, C; Kobayashi, H

Kobayashi, H (reprint author), NCI, Bldg 10,Room B3B69,10 Ctr Dr, Bethesda, MD 20892 USA.

MOLECULAR CANCER RESEARCH, 2017; 15 (12): 1667

Abstract

Oral cavity squamous cell carcinoma (OSCC) is considered one of the most aggressive subtypes of cancer. Anti-CD44 monoclonal antibodies (mAb) are a po......

Full Text Link